In the study that investigated endogenous expression and exogenous effects of both native and In1 variant ghrelins in different prostate cancer cell lines, tumor xenograft, and human tumor samples, In1-ghrelin showed overall more impactful tumor-promoting and oncogenic effects (78). This evidence concerns the gene GHRL and Familial prostate cancer.